160 related articles for article (PubMed ID: 1519604)
21. Remission of nephrotic range proteinuria in type I diabetes. Collaborative Study Group.
Hebert LA; Bain RP; Verme D; Cattran D; Whittier FC; Tolchin N; Rohde RD; Lewis EJ
Kidney Int; 1994 Dec; 46(6):1688-93. PubMed ID: 7700028
[TBL] [Abstract][Full Text] [Related]
22. Reduction of proteinuria with captopril therapy in patients with focal segmental glomerulosclerosis and IgA nephropathy.
Huissoon AP; Meehan S; Keogh JA
Ir J Med Sci; 1991 Oct; 160(10):319-21. PubMed ID: 1810899
[TBL] [Abstract][Full Text] [Related]
23. Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy.
Burns GC; Paul SK; Toth IR; Sivak SL
J Am Soc Nephrol; 1997 Jul; 8(7):1140-6. PubMed ID: 9219164
[TBL] [Abstract][Full Text] [Related]
24. Renal effects of captopril, indomethacin and nifedipine in nephrotic patients after an oral protein load.
Garini G; Mazzi A; Buzio C; Mutti A; Allegri L; Savazzi G; Borghetti A
Nephrol Dial Transplant; 1996 Apr; 11(4):628-34. PubMed ID: 8671850
[TBL] [Abstract][Full Text] [Related]
25. [Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline].
Renke M; Rutkowski P; Tylicki L; Zietkiewicz M; Larczyński W; Rutkowski B
Przegl Lek; 2008; 65(6):312-4. PubMed ID: 18853664
[TBL] [Abstract][Full Text] [Related]
26. [The effect of angiotensin-converting enzyme inhibitors on proteinuria in chronic glomerulonephritis].
Erley CM; Komini E; Nicaeus T; Braun N; Wolf S; Risler T
Dtsch Med Wochenschr; 1994 Jan; 119(4):89-95. PubMed ID: 8299527
[TBL] [Abstract][Full Text] [Related]
27. Diabetic nephropathy and pregnancy: the effect of ACE inhibitors prior to pregnancy on fetomaternal outcome.
Hod M; van Dijk DJ; Karp M; Weintraub N; Rabinerson D; Bar J; Peled Y; Erman A; Boner G; Ovadia J
Nephrol Dial Transplant; 1995 Dec; 10(12):2328-33. PubMed ID: 8808235
[TBL] [Abstract][Full Text] [Related]
28. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
Laffel LM; McGill JB; Gans DJ
Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
[TBL] [Abstract][Full Text] [Related]
29. [The use of angiotensin-converting enzyme inhibitors in patients with chronic glomerulonephritis].
Dudar IO
Lik Sprava; 1999; (7-8):55-9. PubMed ID: 10672690
[TBL] [Abstract][Full Text] [Related]
30. Additive antiproteinuric effect of combination therapy with ACE inhibitor and angiotensin II receptor antagonist: differential short-term response between IgA nephropathy and diabetic nephropathy.
Kim MJ; Song JH; Suh JH; Lee SW; Kim GA
Yonsei Med J; 2003 Jun; 44(3):463-72. PubMed ID: 12833584
[TBL] [Abstract][Full Text] [Related]
31. Contrasting effects of calcium channel blockade versus converting enzyme inhibition on proteinuria in African Americans with non-insulin-dependent diabetes mellitus and nephropathy.
Guasch A; Parham M; Zayas CF; Campbell O; Nzerue C; Macon E
J Am Soc Nephrol; 1997 May; 8(5):793-8. PubMed ID: 9176849
[TBL] [Abstract][Full Text] [Related]
32. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
Tylicki L; Rutkowski P; Renke M; Rutkowski B
Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
[TBL] [Abstract][Full Text] [Related]
33. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C; Torres DD; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[TBL] [Abstract][Full Text] [Related]
34. [Lack of effect of ACE inhibition on severe proteinuria in diabetic nephropathy--a 6-month-long study].
Hay U; Ludvik B; Gisinger C; Schernthaner G
Schweiz Med Wochenschr; 1988 Feb; 118(5):165-9. PubMed ID: 3278375
[TBL] [Abstract][Full Text] [Related]
35. The natural history of the non-nephrotic membranous nephropathy patient.
Hladunewich MA; Troyanov S; Calafati J; Cattran DC;
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1417-22. PubMed ID: 19661220
[TBL] [Abstract][Full Text] [Related]
36. Effect of angiotensin-converting enzyme inhibitor therapy on proteinuria in children with renal disease.
Trachtman H; Gauthier B
J Pediatr; 1988 Feb; 112(2):295-8. PubMed ID: 2828592
[No Abstract] [Full Text] [Related]
37. Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome.
Milliner DS; Morgenstern BZ
Pediatr Nephrol; 1991 Sep; 5(5):587-90. PubMed ID: 1911144
[TBL] [Abstract][Full Text] [Related]
38. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
Song JH; Lee SW; Suh JH; Kim ES; Hong SB; Kim KA; Kim MJ
Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
[TBL] [Abstract][Full Text] [Related]
39. Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes and with non-diabetic renal diseases.
Liou HH; Huang TP; Campese VM
Nephron; 1995; 69(1):41-8. PubMed ID: 7891796
[TBL] [Abstract][Full Text] [Related]
40. Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome.
Shapira Y; Mor F; Friedler A; Wysenbeek AJ; Weinberger A
Ann Rheum Dis; 1990 Sep; 49(9):725-7. PubMed ID: 2241292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
